The Magazine for Sleep Professionals
Tuesday, May 5, 2026
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug Administration (FDA) has granted the Company De Novo clearance for the Hemolung Respiratory Assist System. The Hemolung System is the first and only […]
ALung Technologies, Inc. announced the recent initiation of commercial development of its next-generation artificial lung, which expands the Company’s focus on highly efficient gas exchange devices and also broadens its applicable market. The Company’s current product, the Hemolung® Respiratory Assist System (RAS), is the only fully comprehensive extracorporeal carbon dioxide removal […]
